Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2014 08:45 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial

NEW YORK, NY--(Marketwired - Apr 17, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has once again delivered a major announcement as it advances its pancreatic cancer treatment toward late phase clinical...